International Digestive Disease Forum (IDDF) 2023

10 June 2023 - 11 July 2023

HBsAg a promising biomarker to predict CHB cure and HCC

Kanas Chan, 20230807000000

Hepatitis B surface antigen (HBsAg) levels predict functional cure (ie, HBsAg loss) and hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB), according to studies presented at IDDF 2023.

Minimal monitoring feasible in HCV patients on SOF/VEL

Kanas Chan, 20230726030924

Minimal monitoring is feasible in patients with active hepatitis C virus (HCV) infection treated with sofosbuvir/velpatasvir (SOF/VEL), with high rates of sustained virologic response (SVR) reported, including in patients with novel HCV subtypes, according to new data from the phase IV MINMON study presented at IDDF 2023.